bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis
Source abstract
Abstract
Current therapeutic angiogenesis strategies are focused on the development of biologically responsive scaffolds that can deliver multiple angiogenic cytokines and/or cells in ischemic regions. Herein, we report on a novel electrospinning approach to fabricate cytokine-containing nanofibrous scaffolds with tunable architecture to promote angiogenesis. Fiber diameter and uniformity were controlled by varying the concentration of the polymeric (i.e. gelatin) solution, the feed rate, needle to collector distance, and electric field potential between the collector plate and injection needle. Scaffold fiber orientation (random vs. aligned) was achieved by alternating the polarity of two parallel electrodes placed on the collector plate thus dictating fiber deposition patterns. Basic fibroblast growth factor (bFGF) was physically immobilized within the gelatin scaffolds at variable concentrations and human umbilical vein endothelial cells (HUVEC) were seeded on the top of the scaffolds. Cell proliferation and migration was assessed as a function of growth factor loading and scaffold architecture. HUVECs successfully adhered onto gelatin B scaffolds and cell proliferation was directly proportional to the loading concentrations of the growth factor (0-100 bFGF ng/mL). Fiber orientation had a pronounced effect on cell morphology and orientation. Cells were spread along the fibers of the electrospun scaffolds with the aligned orientation and developed a spindle-like morphology parallel to the scaffold's fibers. In contrast, cells seeded onto the scaffolds with random fiber orientation, did not demonstrate any directionality and appeared to have a rounder shape. Capillary formation (i.e. sprouts length and number of sprouts per bead), assessed in a 3-D in vitro angiogenesis assay, was a function of bFGF loading concentration (0 ng, 50 ng and 100 ng per scaffold) for both types of electrospun scaffolds (i.e. with aligned or random fiber orientation).
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Nerve injury and regeneration
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Biopolymeric delivery matrices for angiogenic growth factors10.1016/S1054-8807(03)00089-9 ↗
2. Controlled drug delivery in tissue engineering10.1016/j.addr.2007.08.038 ↗
3. Therapeutic angiogenesis for ischemic cardiovascular disease10.1006/jmcc.2000.1329 ↗
4. Therapeutic angiogenesis10.1001/archsurg.1993.01420160061009 ↗
5. Update on therapeutic vascularization strategies10.2217/17460751.4.1.65 ↗
6. Drug releasing systems in cardiovascular tissue engineering10.1111/j.1582-4934.2008.00532.x ↗
7. The extracellular matrix of blood vessels10.2174/138161209787846757 ↗
8. Cardiogenesis and the complex biology of regenerative cardiovascular medicine10.1126/science.1163267 ↗
9. Generating new blood flow: integrating developmental biology and tissue engineering10.1016/j.tcm.2009.01.004 ↗
10. Structure and function of basement membranes10.3181/0703-MR-72 ↗
11. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review10.1021/bm800681k ↗
12. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function10.1152/physrev.00012.2007 ↗
13. Cell fate regulation by coupling mechanical cycles to biochemical signaling pathways10.1016/j.ceb.2009.01.002 ↗
14. Mechanically activated integrin switch controls alpha5 beta1 function10.1126/science.1168441 ↗
15. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model10.1016/j.actbio.2008.07.024 ↗
16. Synergistic angiogenic effect of codelivering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia10.1089/ten.tea.2010.0270 ↗
17. To engineer is to create: the link between engineering and regeneration10.1016/j.tibtech.2005.10.006 ↗
18. Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers10.1016/j.biomaterials.2009.07.063 ↗
19. Heparin binding nanostructures to promote growth of blood vessels10.1021/nl0613555 ↗
20. 3D systems delivering VEGF to promote angiogenesis for tissue engineering10.1016/j.jconrel.2010.11.028 ↗
21. Nanotechnology in vascular tissue engineering: from nanoscaffolding towards rapid vessel biofabrication10.1016/j.tibtech.2008.03.001 ↗
22. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration10.1016/j.biomaterials.2006.08.003 ↗
23. Growth factor-delivery systems for tissue engineering: a materials perspective10.1586/17434440.3.1.29 ↗
24. Substrates for cardiovascular tissue engineering10.1016/j.addr.2011.01.007 ↗
25. Putting electrospun nanofibers to work for biomedical research10.1002/marc.200800381 ↗
26. Formation of fibers by electrospinning10.1016/j.addr.2007.04.020 ↗
27. Electrospun scaffold topography affects endothelial cell proliferation, metabolic activity, and morphology10.1002/jbm.a.32802 ↗
28. Analysis of the effects of the residual charge and gap size on electrospun nanofiber alignment in a gap method10.1088/0957-4484/19/35/355307 ↗
29. Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation10.1089/ten.2005.11.1149 ↗
30. Micro/nano-fabrication technologies for cell biology10.1007/s11517-010-0632-z ↗
31. Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering10.1016/S0142-9612(03)00593-3 ↗
32. Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications
33. In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth10.1016/j.biomaterials.2008.01.022 ↗
34. Electrospun nanofibers: Internal structure and intrinsic orientation10.1002/pola.10609 ↗
35. Novel fabricated matrix via electrospinning for tissue engineering10.1002/jbm.b.30122 ↗
36. Electrostatic field-assisted alignment of electrospun nanofibres10.1088/0957-4484/12/3/329 ↗
37. Continuous electrospinning of aligned polymer nanofibers onto a wire drum collector10.1021/nl0486158 ↗
38. Electrospinning of polymeric and ceramic nanofibers as uniaxially aligned arrays10.1021/nl0344256 ↗
39. Electrospinning of continuous aligned polymer fibers10.1063/1.1647685 ↗
40. Therapeutic angiogenesis using basic fibroblast growth factor and vascular endothelial growth factor using various delivery strategies
41. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation10.1007/s11095-006-9173-4 ↗
42. Cells preferentially grow on rough substrates10.1016/j.biomaterials.2010.06.016 ↗
43. The potential to improve cell infiltration in composite fiber-aligned electrospun scaffolds by the selective removal of sacrificial fibers10.1016/j.biomaterials.2008.01.032 ↗
44. Hamerly G, Elkan C. Alternatives to the k-Means Algorithm That Find Better Clusterings. Proceedings int’l Conference on information and Knowledge Management 2002:600–607.10.1145/584792.584890 ↗
45. Zhang B. Generalized K-harmonic means: boosting in unsupervised learning (HP laboratories technical report): Hewlett–Packard laboratories, 2000. Available from: http://www.hpl.hp.com/techreports/2000/HPL-2000-137.html.
46. Platt JC. Probabilities for SV machines in advances in large margin classifiers. In: Smola A, Bartlett P, Scholkopf B, Schuurmans D, editors. Advances in Large Margin Classifiers, MIT Press; 2000. p. 61–74.10.7551/mitpress/1113.003.0008 ↗
47. Medioni G, Mordohai P, Nicolescu M. The tensor voting framework. In: Eduardo Bayro Corrochano, editors. Handbook of Geometric Computing: Applications in Pattern Recognition, Computer Vision, Neural Computing, and Robotics, Springer-Verlag Berlin Heidelberg; 2005. p. 535–68.10.1007/3-540-28247-5_16 ↗
48. Temperature-sensitive hydrogels: potential therapeutic applications10.2165/00137696-200503040-00004 ↗
49. Gelatin as a delivery vehicle for the controlled release of bioactive molecules10.1016/j.jconrel.2005.09.023 ↗
50. Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size10.1089/ten.2006.12.1775 ↗
51. Biomimetic topography: bioinspired cell culture substrates and scaffolds
52. In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells10.1007/s11060-008-9742-y ↗
53. Chapter 4. An optimized three-dimensional In vitro model for the analysis of angiogenesis10.1016/S0076-6879(08)02004-1 ↗
54. Functionality of endothelial cells on silk fibroin nets: comparative study of micro- and nanometric fibre size10.1016/j.biomaterials.2007.10.002 ↗